Effectiveness of Interleukin-2 (IL-2) Plus Anti-HIV Therapy in HIV-Positive Patients
Status:
Completed
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out if the immune systems of HIV-positive patients can
be improved by treatment with anti-HIV medications plus interleukin-2 (IL-2) in the early
stages of HIV infection.
IL-2 is a protein found naturally in the blood that can help boost the immune system. HIV
spreads throughout the body by invading CD4 cells, which are cells of the immune system that
fight infection. Doctors hope that adding IL-2 to a current anti-HIV drug combination can
help restore the CD4 cell count and the immune functions. This study will look at how the HIV
virus acts during the early stages of HIV infection, how the immune system responds to HIV,
and what impact early treatment with anti-HIV medications has on the course of HIV infection.
Phase:
N/A
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)